← Back to Search

Healthy Aging Program for Epilepsy (HAP-E Trial)

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre and post intervention (3 months)
Awards & highlights
No Placebo-Only Group

Summary

This trial studies an educational program for older adults with epilepsy to improve knowledge of dementia and quality of life. Participants attend a 12-week group program and take pre/post evaluation.

Who is the study for?
This trial is for older adults with epilepsy who can understand English. They should have been diagnosed by a neurologist, epileptologist, or primary care physician. People already diagnosed with dementia cannot participate.
What is being tested?
The study is testing an educational program designed to teach participants about healthy aging and managing chronic diseases, focusing on dementia and lifestyle factors that could affect their quality of life.
What are the potential side effects?
Since this trial involves an educational program rather than medication, there are no direct medical side effects. However, learning about sensitive topics like dementia may cause emotional or psychological discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with epilepsy by a specialist.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre and post intervention (3 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre and post intervention (3 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dementia Knowledge
Health Related Quality of life
Health literacy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: HAP-E Epilepsy ParticipantsExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,180 Previous Clinical Trials
1,574,966 Total Patients Enrolled
3 Trials studying Epilepsy
3,139 Patients Enrolled for Epilepsy
~60 spots leftby Jul 2027